CCR5 and acute myeloid leukemia: For treating acquired immune deficiency syndrome (AIDS) and acute myeloid leukemia (AML), CRISPR-Cas9 was employed to knock out the CCR5 gene in donor HSPCs, which were then transplanted into patients with HIV-associated AML.